Xilio Therapeutics
33 hedge funds and large institutions have $12.6M invested in Xilio Therapeutics in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.01% less ownership
Funds ownership: 39.31% → 36.3% (-3%)
8% less capital invested
Capital invested by funds: $13.7M → $12.6M (-$1.17M)
Holders
33
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$615K | |
| 2 | +$322K | |
| 3 | +$122K | |
| 4 |
EGM
Engineers Gate Manager
New York
|
+$25.8K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$24.6K |
Top Sellers
| 1 | -$22.6K | |
| 2 | -$11.3K | |
| 3 | -$7.43K | |
| 4 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
-$3.56K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$1.42K |